8-K - ParkerVision, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

ParkerVision, Inc. reported financial and operating results for the year ended December 31, 2025, including a net loss of $7.4 million or $0.06 per common share, improved from $14.5 million or $0.16 per share in 2024, primarily due to changes in the fair value of contingent payment obligations. The filing includes updates on expedited CAFC appeal in the Qualcomm case and postponement of the MediaTek trial.

Key Takeaways

1Net loss of $7.4 million or $0.06 per common share for year ended December 31, 2025, vs. $14.5 million or $0.16 per share for 2024

2Cash and cash equivalents of $4.4 million and $2.3 million in working capital as of December 31, 2025

3CAFC granted expedited schedule for ParkerVision v. Qualcomm appeal (case no. 26-1033), with briefings by March 23, 2026

4MediaTek patent infringement trial in Western District of Texas postponed from March 20, 2026 pending expert reports

5Sold 21.2 million common shares at $0.21 per share in November 2025 for $4.5 million gross proceeds

6Issued 3.2 million common shares at $0.21 per share in March 2026 to satisfy $0.67 million convertible note maturities

Current Report Details

Event Type

Financial Results

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

Results of Operations and Financial Condition On March 23, 2026, ParkerVision, Inc. (the “Company”) issued a press release which reported financial and operatin

Financial Results

9.01

. Financial Statements and Exhibits. (d) Exhibits: Exhibit Description 99.1 Press Release 104 Cover Page Interactive Data File (embedded within the Inline XBRL

Exhibits Only

Source Document

Results of Operations

Year Ended December 31, 2025

Metric	Value	Basis	Prior Period
Licensing revenue	$0.00	GAAP	$0.00
Net loss	$-7.40	GAAP	$-14.50
Basic and diluted net loss per common share	$-0.06	GAAP	$-0.16

Exhibits (2)

8-K

FORM 8-K

99.1

PRESS RELEASE